Pacific Biosciences Of California PACB
NASDAQ PACB
$2.09 -0.15 (-6.92%)
As of: Nov 11, 2026 · 3:27 PM EST

Pacific Biosciences Of California (PACB) Price to Earnings (2020)

Updated

Pacific Biosciences Of California's Price to Earnings came in at 169.65 for Q4 2020.

Analysis

Pacific Biosciences Of California (PACB) Price to Earnings (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn
10 Pacific Biosciences Of California 699.41 Mn -292.35 Mn 13.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 169.65
API Access

Pacific Biosciences Of California Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=PACB&period=max&api_key=YOUR_API_KEY